NCT00002715View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 1989

Primary Completion Date

January 31, 2007

Study Completion Date

October 31, 2015

Conditions
Lymphoma
Interventions
BIOLOGICAL

Bleomycin sulfate

A component of the Stanford V regimen.

DRUG

Stanford V regimen

DRUG

Doxorubicin hydrochloride

A component of the Stanford V regimen.

DRUG

Etoposide

A component of the Stanford V regimen.

DRUG

Mechlorethamine hydrochloride

A component of the Stanford V regimen.

DRUG

Prednisone

A component of the Stanford V regimen.

DRUG

Vinblastine

A component of the Stanford V regimen.

DRUG

Vincristine sulfate

A component of the Stanford V regimen.

Trial Locations (1)

94305

Stanford Cancer Center at Stanford University Medical Center, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER